December 12, 2023 02:14 PM EST
Pharma
FDA+

FDA es­tab­lish­es new ad­vi­so­ry com­mit­tee for ge­net­ic meta­bol­ic dis­ease treat­ments

Lia DeGroot

The FDA is as­sem­bling a new ad­vi­so­ry com­mit­tee to eval­u­ate po­ten­tial treat­ments for ge­net­ic meta­bol­ic dis­eases, the agency an­nounced Tues­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Stem cell start­up spun out of George Church’s lab rais­es $75M

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

Up­stream Bio files for IPO in sign of life for biotech pub­lic of­fer­ings

Edge­wise’s stock surges as heart drug pass­es ear­ly safe­ty test

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times